Board expansion strengthens governance, strategic leadership, and capital markets engagement as Immorta Bio advances toward the clinic MIAMI, May 21, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity company focused on Treating Diseases of Aging and Treating Aging as Disease™,...
Hence then, the article about scientific longevity company immorta bio appoints former ernst young health sciences partner howard brooks to corporate board of directors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors )
Also on site :
- Box Office Smash That ‘Saved Cinema’ Is Now Streaming Free for the First Time Ever
- Politics latest: Reeves to cut food costs and offer free children’s bus rides in cost of living package
- Chelsea Handler Slams ‘Bigots’ Shane Gillis and Tony Hinchcliffe for ‘Racist’ Roast Jokes: ‘I Wasn’t Fine With That’